Breast Cancer
New clues to breast cancer development in high-risk women
Published in OBGYN and Reproduction Week, September 24th, 2007
Physicians who treat women with the breast cancer susceptibility gene BRCA1 often remove their patients’ ovaries to eliminate the source of estrogen they believe fuels cancer growth. Yet they also know that anti-estrogen therapies don't work to treat breast or ovarian cancer that might develop. That paradox has led scientists to question exactly how, or if, estrogen is involved in cancer development and whether removal of ovaries makes sense.
Now, a team of researchers from Georgetown University’s Lombardi Comprehensive Cancer Center have shed light on the mechanism that makes ovary removal protective against tumor development in this unique population. They discovered...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week
More Articles from OBGYN and Reproduction Week
- Biomedicine
Don't just save her life, save her fertility - Cervical Cancer
Cervical cancer burden can be solved with current technology and modest resources - Cervical Cancer Screening
Ovarian Cancer: the Not-so-silent Killer - Eating Disorders
Pregnancy may increase the risk of developing binge eating disorder - Endometrial Cancer
Frequent alcohol consumption increases cancer risk in older women - Obesity and Diabetes
Drug could improve pregnancy outcomes in wider range of women with insulin resistance - More from this issue of OBGYN and Reproduction Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
